Literature DB >> 11961616

The impact of splenic weight on laparoscopic splenectomy for splenomegaly.

G Terrosu1, U Baccarani, V Bresadola, M A Sistu, A Uzzau, F Bresadola.   

Abstract

BACKGROUND: Enlarged spleens increase the technical difficulties associated with laparoscopic splenectomy (LS). The aim of this study was to analyze the impact of splenic weight on the results of LS.
METHODS: We performed a prospective analysis of 20 LS for splenomegaly and 40 LS for normal spleen in terms of intraoperative and early postoperative outcome.
RESULTS: Patients with splenomegaly had longer operative times and higher conversion and transfusion rates than those with normal spleens. Patients with spleens weighing < 2000 G experienced less blood loss, fewer conversions, and a shorter postoperative hospital stay than those with spleens > 2000 g. No differences-except for the longer operative time-were observed between normal-sized spleens and those weighing < 2000 G.
CONCLUSIONS: LS for splenomegaly is feasible for experienced laparoscopic surgeons. For spleens weighing < 2000 G, the outcome was comparable to that of normal spleens, whereas LS for spleens >2000 g was associated with a higher conversion rate, greater blood loss, a longer hospital stay, and increased morbidity.

Entities:  

Mesh:

Year:  2001        PMID: 11961616     DOI: 10.1007/s00464-001-9045-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  14 in total

1.  Laparoscopic splenectomy for hematologic diseases: a preliminary analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS).

Authors:  M Casaccia; P Torelli; S Squarcia; M P Sormani; A Savelli; B Troilo; G Santori; U Valente
Journal:  Surg Endosc       Date:  2006-07-03       Impact factor: 4.584

2.  Laparoscopic splenectomy: a surgeon's experience of 302 patients with analysis of postoperative complications.

Authors:  Xin Wang; Yongbin Li; Nicolas Crook; Bing Peng; Ting Niu
Journal:  Surg Endosc       Date:  2013-08-24       Impact factor: 4.584

3.  A meta-analysis of perioperative outcomes of laparoscopic splenectomy for hematological disorders.

Authors:  Yan-Nan Bai; Hui Jiang; Pankaj Prasoon
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

4.  Laparoscopic splenectomy: the latest technical evaluation.

Authors:  Min Tan; Chao-Xu Zheng; Zhi-Mian Wu; Guo-Tai Chen; Liu-Hua Chen; Zhen-Xian Zhao
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

5.  Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  B Habermalz; S Sauerland; G Decker; B Delaitre; J-F Gigot; E Leandros; K Lechner; M Rhodes; G Silecchia; A Szold; E Targarona; P Torelli; E Neugebauer
Journal:  Surg Endosc       Date:  2008-02-22       Impact factor: 4.584

6.  Laparoscopic splenectomy: a single center experience. Unusual cases and expanded inclusion criteria for laparoscopic approach.

Authors:  Gianpaolo Marte; Vincenzo Scuderi; Aldo Rocca; Giuseppe Surfaro; Carla Migliaccio; Antonio Ceriello
Journal:  Updates Surg       Date:  2013-01-26

7.  Laparoscopic splenectomy for massive splenomegaly in benign hematological diseases.

Authors:  Abdulrahman Saleh Al-Mulhim
Journal:  Surg Endosc       Date:  2012-05-12       Impact factor: 4.584

8.  Laparoscopic splenectomy using conventional instruments.

Authors:  A N Dalvi; P M Thapar; A A Deshpande; S A Rege; R Y Prabhu; A N Supe; R S Kamble
Journal:  J Minim Access Surg       Date:  2005-06       Impact factor: 1.407

9.  Laparoscopic splenectomy in patients of β thalassemia: Our experience.

Authors:  Nirmal M Patle; Om Tantia; Prakash Kumar Sasmal; Shashi Khanna; Bimalendu Sen
Journal:  J Minim Access Surg       Date:  2010-07       Impact factor: 1.407

10.  Laparoscopic versus open splenectomy for splenomegaly: the verdict is unclear.

Authors:  Reuben D Shin; Roger Lis; Nicholas R Levergood; David C Brooks; Brent T Shoji; Ali Tavakkoli
Journal:  Surg Endosc       Date:  2018-08-27       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.